BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Five Prime Therapeutics, Inc. 

1650 Owens Street
Suite 200
San Francisco  California  94158  U.S.A.
Phone: 415-365-5600 Fax: 415-365-5601


SEARCH JOBS










 Company News
J.P. Morgan: Five Prime Therapeutics, Inc. (FPRX) CEO Says Experimental Drug to Head Into Six New Tumor Trials Via Bristol-Myers Squibb Company (BMY) 1/15/2015 1:19:13 PM
Five Prime Therapeutics, Inc. (FPRX) Announces Closing Of Public Offering 1/12/2015 8:06:27 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/9/2015 8:07:42 AM
Five Prime Therapeutics, Inc. (FPRX) Prices Public Offering Of Common Stock 1/7/2015 7:23:12 AM
Five Prime Therapeutics, Inc. (FPRX) Announces $75 Million Proposed Public Offering Of Common Stock 1/6/2015 7:50:32 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014 12:12:53 PM
Five Prime Therapeutics, Inc. (FPRX) Initiates Patient Dosing In Phase 1 Clinical Trial Evaluating FPA144 In Gastric Cancer 12/5/2014 9:50:43 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014 10:51:17 AM
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types 11/24/2014 8:44:55 AM
Five Prime Therapeutics, Inc. (FPRX) Initiates Dosing Of Rheumatoid Arthritis Patients In Its Phase 1 Clinical Trial Of FPA008 11/17/2014 4:21:24 PM
123456789